Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

Polling Question:

In your experience, what have most studies about CGM demonstrated?
HbA1c is lower in CGM users regardless of age or type of insulin delivery
Patients using MDI + CGM have greater reductions in HbA1c1c than those using CSII + CGM
Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups
All of the above

©2020 CogniMed Inc. All rights reserved.